Pyridium and Restasis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pyridium (phenazopyridine hydrochloride) and Restasis (cyclosporine). Common drug interactions include fall among females.

The phase IV clinical study analyzes what interactions people have when they take Pyridium and Restasis. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Pyridium?

Pyridium has active ingredients of phenazopyridine hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 1,841 Pyridium users. Check the latest studies of Pyridium.

What is Restasis?

Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 25, 2026

59 people who take Pyridium and Restasis together, and have interactions are studied.

Pyridium and Restasis drug interactions.

What are the common drug interactions of Pyridium and Restasis, by gender? *:

female:

  1. Fall
  2. Renal failure (kidney dysfunction)
  3. Muscular weakness (muscle weakness)
  4. Osteoporosis (bones weak and more likely to break)
  5. Pain
  6. Asthenia (weakness)
  7. Chest pain
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  10. Hypoaesthesia (reduced sense of touch or sensation)

male:

n/a

What are the common drug interactions of Pyridium and Restasis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Haemorrhagic diathesis (bleeding tendency)
  3. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

20-29:

n/a

30-39:

  1. Glaucoma (increased fluid pressure in the eye with vision loss)
  2. Paraneoplastic retinopathy
  3. Retinal disorder (disease of retina)
  4. Injection site pain
  5. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)

40-49:

  1. Injection site mass
  2. Injection site pain
  3. Injection site reaction

50-59:

  1. Cough
  2. Hypokalaemia (low potassium)
  3. Loss of consciousness
  4. Memory impairment
  5. Acute respiratory failure
  6. Asthenia (weakness)
  7. Bladder dysfunction
  8. Bradycardia (abnormally slow heart action)
  9. Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
  10. Colitis ulcerative (inflammation of colon with ulcer)

60+:

  1. Drug ineffective
  2. Asthenia (weakness)
  3. Fall
  4. Hyperhidrosis (abnormally increased sweating)
  5. Impaired gastric emptying
  6. Lymphocyte count decreased
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Mobility decreased (ability to move is reduced)
  9. Vomiting
  10. Weight decreased

What are the existing conditions these people have? *

  1. Pain: 13 people, 22.03%
  2. Stress And Anxiety: 9 people, 15.25%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 11.86%
  4. Depression: 7 people, 11.86%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 11.86%
  6. Muscle Spasms (muscle contraction): 6 people, 10.17%
  7. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 10.17%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 10.17%
  9. Fluid Imbalance (imbalance of fluid in body in intake and fluid lost): 5 people, 8.47%
  10. Nausea (feeling of having an urge to vomit): 5 people, 8.47%

* Approximation only. Some reports may have incomplete information.

Do you take Pyridium and Restasis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pyridium and Restasis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pyridium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Restasis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pyridium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Restasis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on phenazopyridine hydrochloride and cyclosporine (the active ingredients of Pyridium and Restasis, respectively), and Pyridium and Restasis (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: